Ishare Nasdaq Biotech ETF (NASDAQ:IBB)’s share price plunged -0.57% or -0.6 to reach at $104.54 during previous trading session. A total of 6.19 Million shares exchanged hands, whereas the company’s average trading volume stands at 2.37 Million shares. Ishare Nasdaq Biotech ETF (NASDAQ:IBB) has a market capitalization of $0 and most recently 0 outstanding shares have been calculated.

Ishare Nasdaq Biotech ETF (NASDAQ:IBB)’s shares slipped -6.58% in the past week and plunged -7.63% in the last 4 weeks, historically the stock illustrate that its six months performance stands at -8.9% while its year to date performance is at 8.41%.

While taking a glance at financials, we can look at a number of key indicators. Ishare Nasdaq Biotech ETF (NASDAQ:IBB) has a Return on Assets (ROA) of 0. The company currently has a Return on Equity (ROE) of 0 and a Return on Investment (ROI) of 0. Average true range (ATR-14) of the company sets at 2.28, along with its weekly and monthly volatility of 2.83% and 1.94% respectively. Relative strength index (RSI-14) for Ishare Nasdaq Biotech ETF (NASDAQ:IBB) is at 32.06. Beta value of the stock stands at 0.

The company’s price to free cash flow for trailing twelve months is 0. Its quick ratio for most recent quarter is 0 along with current ratio for most recent quarter of 0. Total debt to equity ratio of Ishare Nasdaq Biotech ETF (NASDAQ:IBB) for most recent quarter is 0 whereas long term debt to equity ratio for most recent quarter is 0.

Shares of 21St Centry Fox Class B (NASDAQ:FOX) plunged -0.76% or -0.29 to reach at $37.92 during previous trading session. 21St Centry Fox Class B (NASDAQ:FOX) has a market capitalization of $0 and most recently 0 outstanding shares have been calculated. A total of 2.32 Million shares exchanged hands, whereas the company’s average trading volume stands at 2.48 Million shares.

According to 1 analysts 21St Centry Fox Class B (NASDAQ:FOX)’s price will reach at $51.5 during 52 weeks. Stock’s minimum price target estimates has been figured out at $51.5 while the maximum price target forecast is established at $51.5.

According to the recommendations from 1 analysts stock has mean rating of 1 on the shares of 21St Centry Fox Class B (NASDAQ:FOX). Out of rating recommendations 6 have given the stock a Buy while 5 recommend the stock as Outperform. 7 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Shares of 21St Centry Fox Class B (NASDAQ:FOX) climbed 4.15% in the past week and soared 0.85% in the last 4 weeks, historically the stock illustrate that its six months performance stands at 0% while its year to date performance is at -3.27%.

Total debt to equity ratio of 21St Centry Fox Class B (NASDAQ:FOX) for most recent quarter is 0 whereas long term debt to equity ratio for most recent quarter is 0. The company’s price to free cash flow for trailing twelve months is 0. Its quick ratio for most recent quarter is 0 along with current ratio for most recent quarter of 0.

Average true range (ATR-14) of the company sets at 0.99, along with its weekly and monthly volatility of 1.93% and 2.51% respectively. Relative strength index (RSI-14) for 21St Centry Fox Class B (NASDAQ:FOX) is at 0. Beta value of the stock stands at 0. 21St Centry Fox Class B (NASDAQ:FOX) has a Return on Assets (ROA) of 0. The company currently has a Return on Equity (ROE) of 0 and a Return on Investment (ROI) of 0.